Advertisement
Advertisement
U.S. Markets open in 1 hr 41 mins
Advertisement
Advertisement
Advertisement
Advertisement

Fisher & Paykel Healthcare Corporation Limited (FPH.AX)

ASX - ASX Delayed Price. Currency in AUD
21.09+1.89 (+9.84%)
At close: 04:10PM AEDT
Advertisement

Fisher & Paykel Healthcare Corporation Limited

15 Maurice Paykel Place
East Tamaki
Auckland 2013
New Zealand
64 9 574 0100
https://www.fphcare.com

Sector(s)Healthcare
IndustryMedical Instruments & Supplies
Full Time Employees6,769

Key Executives

NameTitlePayExercisedYear Born
Mr. Lewis G. GradonMD, CEO & Exec. Director1.69MN/A1961
Ms. Lyndal YorkChief Financial OfficerN/AN/AN/A
Dr. Andrew SomervellVP of Products & TechnologyN/AN/AN/A
Hayden BrownInvestor Relations Mang.N/AN/AN/A
Karen KnottGen. Mang. of Corp. CommunicationsN/AN/AN/A
Mr. Paul N. Shearer B.Com.Sr. VP of Sales & MarketingN/AN/AN/A
Ms. Nicola TalbotVP of HRN/AN/AN/A
Mr. Jonathan RhodesVP of Supply Chain, Facilities & SustainabilityN/AN/AN/A
Mr. Marcus DrillerVP of Corp. & Company Sec.N/AN/AN/A
Chris CroneGen. Mang. of Airvo OptiflowN/AN/AN/A
Amounts are as of December 31, 2022 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in AUD.

Description

Fisher & Paykel Healthcare Corporation Limited, together with its subsidiaries, designs, manufactures, markets, and sells medical device products and systems worldwide. It also provides its products for use in acute and chronic respiratory care, and surgery, as well as the treatment of obstructive sleep apnea (OSA) in the home and hospital. The company offers Airvo 2, a humidified nasal high flow system; Optiflow, a nasal high flow therapy; and F&P 850 System, a noninvasive and invasive ventilation system. In addition, it provides infant respiratory products, such as resuscitation, continuous positive airway pressure (CPAP) therapy, and nasal high flow therapy products. Further, the company offers hospital products, including humidification products, breathing circuits, chambers, masks, nasal cannulas, surgical, accessories, and interfaces; and homecare products that include masks, CPAP devices, software and data management products, humidifiers, and accessories. Fisher & Paykel Healthcare Corporation Limited was founded in 1934 and is headquartered in Auckland, New Zealand.

Corporate Governance

Fisher & Paykel Healthcare Corporation Limited’s ISS Governance QualityScore as of October 1, 2022 is 8. The pillar scores are Audit: 10; Board: 5; Shareholder Rights: 7; Compensation: 9.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.
Advertisement
Advertisement